polyclonal anti-p24 rabbit serum Search Results


96
Santa Cruz Biotechnology mouse anti p24 serum
Mouse Anti P24 Serum, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/pm36815832-441-16-32?v=Santa+Cruz+Biotechnology
Average 96 stars, based on 1 article reviews
mouse anti p24 serum - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
SAIC-Frederick Inc rabbit anti-hiv-p24 serum
Rabbit Anti Hiv P24 Serum, supplied by SAIC-Frederick Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/pm16298167-186-24-27?v=SAIC-Frederick+Inc
Average 90 stars, based on 1 article reviews
rabbit anti-hiv-p24 serum - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GENTAUR Inc mouse anti-p24 clone 38/8.7.47
Mouse Anti P24 Clone 38/8.7.47, supplied by GENTAUR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/pmc03070099-211-18-23?v=GENTAUR+Inc
Average 90 stars, based on 1 article reviews
mouse anti-p24 clone 38/8.7.47 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

99
NSJ Bioreagents ha tag antibody
Ha Tag Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/custom%40f52057%4020386718?v=NSJ+Bioreagents
Average 99 stars, based on 1 article reviews
ha tag antibody - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

90
Biosynth Carbosynth rabbit anti p24
Figure 2. mTOR activity is required for optimal viral-protein synthesis. (a) Schematic of experimental protocol. (b) HeLa cells were transfected with pNL4-3, left untreated or treated with 250 nM Torin1 in medium containing AHA. At the indicated times, cell lysates were collected and Click-it chemistry was performed followed by immunoprecipitation with rabbit <t>anti-p24</t> antibody. Membranes were probed with the indicated antibodies. (c) Densitometry quantification of de novo synthesized, biotinylated Gag from panel b was determined by ImageJ analysis. For each time point, the values presented in the graph are normalized against the total amount of Gag in the cell lysate (refer to Supplementary Fig. 1 for total protein synthesis). Full-length blots are shown in Supplementary Fig. 5. (d) HeLa cells were transfected with either pcDNA3.1 or pNL4-3 and infected with L. major (lmj) WT or GP63 KO. Cell lysates were subjected to SDS-PAGE, immunoblotted and probed with the indicated antibodies against host (left panels) and viral (right panels) antigens.
Rabbit Anti P24, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/pm28710431-272-23-25?v=Biosynth+Carbosynth
Average 90 stars, based on 1 article reviews
rabbit anti p24 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
GENTAUR Inc rabbit anti-f serum f 431
Figure 2. mTOR activity is required for optimal viral-protein synthesis. (a) Schematic of experimental protocol. (b) HeLa cells were transfected with pNL4-3, left untreated or treated with 250 nM Torin1 in medium containing AHA. At the indicated times, cell lysates were collected and Click-it chemistry was performed followed by immunoprecipitation with rabbit <t>anti-p24</t> antibody. Membranes were probed with the indicated antibodies. (c) Densitometry quantification of de novo synthesized, biotinylated Gag from panel b was determined by ImageJ analysis. For each time point, the values presented in the graph are normalized against the total amount of Gag in the cell lysate (refer to Supplementary Fig. 1 for total protein synthesis). Full-length blots are shown in Supplementary Fig. 5. (d) HeLa cells were transfected with either pcDNA3.1 or pNL4-3 and infected with L. major (lmj) WT or GP63 KO. Cell lysates were subjected to SDS-PAGE, immunoblotted and probed with the indicated antibodies against host (left panels) and viral (right panels) antigens.
Rabbit Anti F Serum F 431, supplied by GENTAUR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/pm25715658-91-5-25?v=GENTAUR+Inc
Average 90 stars, based on 1 article reviews
rabbit anti-f serum f 431 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

95
ProSci Incorporated mouse anti p24 monoclonal antibodies
Figure 2. mTOR activity is required for optimal viral-protein synthesis. (a) Schematic of experimental protocol. (b) HeLa cells were transfected with pNL4-3, left untreated or treated with 250 nM Torin1 in medium containing AHA. At the indicated times, cell lysates were collected and Click-it chemistry was performed followed by immunoprecipitation with rabbit <t>anti-p24</t> antibody. Membranes were probed with the indicated antibodies. (c) Densitometry quantification of de novo synthesized, biotinylated Gag from panel b was determined by ImageJ analysis. For each time point, the values presented in the graph are normalized against the total amount of Gag in the cell lysate (refer to Supplementary Fig. 1 for total protein synthesis). Full-length blots are shown in Supplementary Fig. 5. (d) HeLa cells were transfected with either pcDNA3.1 or pNL4-3 and infected with L. major (lmj) WT or GP63 KO. Cell lysates were subjected to SDS-PAGE, immunoblotted and probed with the indicated antibodies against host (left panels) and viral (right panels) antigens.
Mouse Anti P24 Monoclonal Antibodies, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/pmc03758239-142-28-26?v=ProSci+Incorporated
Average 95 stars, based on 1 article reviews
mouse anti p24 monoclonal antibodies - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

90
Profectus BioSciences Inc p24 capture elisa
Figure 2. mTOR activity is required for optimal viral-protein synthesis. (a) Schematic of experimental protocol. (b) HeLa cells were transfected with pNL4-3, left untreated or treated with 250 nM Torin1 in medium containing AHA. At the indicated times, cell lysates were collected and Click-it chemistry was performed followed by immunoprecipitation with rabbit <t>anti-p24</t> antibody. Membranes were probed with the indicated antibodies. (c) Densitometry quantification of de novo synthesized, biotinylated Gag from panel b was determined by ImageJ analysis. For each time point, the values presented in the graph are normalized against the total amount of Gag in the cell lysate (refer to Supplementary Fig. 1 for total protein synthesis). Full-length blots are shown in Supplementary Fig. 5. (d) HeLa cells were transfected with either pcDNA3.1 or pNL4-3 and infected with L. major (lmj) WT or GP63 KO. Cell lysates were subjected to SDS-PAGE, immunoblotted and probed with the indicated antibodies against host (left panels) and viral (right panels) antigens.
P24 Capture Elisa, supplied by Profectus BioSciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/10__1089_slash_aid__2015__0378-66-25-30?v=Profectus+BioSciences+Inc
Average 90 stars, based on 1 article reviews
p24 capture elisa - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

96
Equitech-Bio inc normal mouse serum
Figure 2. mTOR activity is required for optimal viral-protein synthesis. (a) Schematic of experimental protocol. (b) HeLa cells were transfected with pNL4-3, left untreated or treated with 250 nM Torin1 in medium containing AHA. At the indicated times, cell lysates were collected and Click-it chemistry was performed followed by immunoprecipitation with rabbit <t>anti-p24</t> antibody. Membranes were probed with the indicated antibodies. (c) Densitometry quantification of de novo synthesized, biotinylated Gag from panel b was determined by ImageJ analysis. For each time point, the values presented in the graph are normalized against the total amount of Gag in the cell lysate (refer to Supplementary Fig. 1 for total protein synthesis). Full-length blots are shown in Supplementary Fig. 5. (d) HeLa cells were transfected with either pcDNA3.1 or pNL4-3 and infected with L. major (lmj) WT or GP63 KO. Cell lysates were subjected to SDS-PAGE, immunoblotted and probed with the indicated antibodies against host (left panels) and viral (right panels) antigens.
Normal Mouse Serum, supplied by Equitech-Bio inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/pmc06224806-292-36-40?v=Equitech-Bio+inc
Average 96 stars, based on 1 article reviews
normal mouse serum - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

90
FUJIFILM mouse anti-ago2
RNAi is functional and the localizations of its contributors remain unchanged in HIV-expressing cells. (A) Silencing of EGFP expression by shGFP and miGFP remains functional in HIV-1 expressing cells. HeLa cells were co- transfected with 2 µg of pcDNA3 or pNL4-3, 1 µg of pEGFP-C1 and 4µg of shRNA-NS, shRNA-EGFP, miRNA-NS or miRNA-EGFP, as indicated. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (B) Inhibition of endogenous and transfected GAPDH expression by shGAPDH is functional in HIV- expressing cells. HeLa cells were co-transfected with 2 µg pcDNA3 or pNL4-3, 1 µg GAPDH-ProLabel and 1 µg pSIREN-shRNA-LucIRR or pSIREN-shRNA-GAPDHB. GAPDH, HIV-1 Gag and actin expression were observed by immunoblot and GAPDH silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (C) Inhibition of EGFP expression by let7 is functional in HIV-1 replicating cells. HeLa-CD4 (MAGI) cells were not infected (lanes 1, 2) or infected with pNL4-3 at one million RT cpms (lanes 3, 4) or 2 million RT cpms (lanes 5, 6) of supernatant. They were co-transfected with pEGFP or pEGFP-clet7 24 h later. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (D) The number of large GWBs is not altered in HIV-1 expressing cells. HeLa cells were transfected with 0.2 µg of HIV-1 pNL4-3. Cells were fixed and stained 48 h later with the human GWB marker serum 18033 and an antibody targeting HIV-1 p24. Side-by-side images of p24 positive (+ve) and negative (-ve) cells were identified and images were adjusted to visualize only large 18033 stained GWBs, which were then counted. The bar graph shows the mean number of GWBs from 12 pairs of cells. Statistical analysis was performed using an unpaired Mann-Whitney test (p=0.7) between +ve or –ve cells. (E-H) The localization of miRNA biogenesis enzymes and RNAi proteins in the cytoplasm is not altered in HIV-1 expressing cells . HeLa cells were transfected, fixed and stained as in (D) with the addition of antibodies against DDX6 (E), <t>Ago2</t> (F), TRBP (G) or Dicer (H). The size scale is 20 µm and is shown in each picture on the bottom left. Digitally zoomed images of the merged channels are shown on the far right, with arrows highlighting colocalization between the GWB marker 18033 and DDX6 (E) or Ago2 (F), shown as cyan and purple dots, respectively.
Mouse Anti Ago2, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/bio_rxiv__2023__05__24__542197-238-46-48?v=FUJIFILM
Average 90 stars, based on 1 article reviews
mouse anti-ago2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
RPI Inc fraction v bovine serum albumin (bsa
RNAi is functional and the localizations of its contributors remain unchanged in HIV-expressing cells. (A) Silencing of EGFP expression by shGFP and miGFP remains functional in HIV-1 expressing cells. HeLa cells were co- transfected with 2 µg of pcDNA3 or pNL4-3, 1 µg of pEGFP-C1 and 4µg of shRNA-NS, shRNA-EGFP, miRNA-NS or miRNA-EGFP, as indicated. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (B) Inhibition of endogenous and transfected GAPDH expression by shGAPDH is functional in HIV- expressing cells. HeLa cells were co-transfected with 2 µg pcDNA3 or pNL4-3, 1 µg GAPDH-ProLabel and 1 µg pSIREN-shRNA-LucIRR or pSIREN-shRNA-GAPDHB. GAPDH, HIV-1 Gag and actin expression were observed by immunoblot and GAPDH silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (C) Inhibition of EGFP expression by let7 is functional in HIV-1 replicating cells. HeLa-CD4 (MAGI) cells were not infected (lanes 1, 2) or infected with pNL4-3 at one million RT cpms (lanes 3, 4) or 2 million RT cpms (lanes 5, 6) of supernatant. They were co-transfected with pEGFP or pEGFP-clet7 24 h later. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (D) The number of large GWBs is not altered in HIV-1 expressing cells. HeLa cells were transfected with 0.2 µg of HIV-1 pNL4-3. Cells were fixed and stained 48 h later with the human GWB marker serum 18033 and an antibody targeting HIV-1 p24. Side-by-side images of p24 positive (+ve) and negative (-ve) cells were identified and images were adjusted to visualize only large 18033 stained GWBs, which were then counted. The bar graph shows the mean number of GWBs from 12 pairs of cells. Statistical analysis was performed using an unpaired Mann-Whitney test (p=0.7) between +ve or –ve cells. (E-H) The localization of miRNA biogenesis enzymes and RNAi proteins in the cytoplasm is not altered in HIV-1 expressing cells . HeLa cells were transfected, fixed and stained as in (D) with the addition of antibodies against DDX6 (E), <t>Ago2</t> (F), TRBP (G) or Dicer (H). The size scale is 20 µm and is shown in each picture on the bottom left. Digitally zoomed images of the merged channels are shown on the far right, with arrows highlighting colocalization between the GWB marker 18033 and DDX6 (E) or Ago2 (F), shown as cyan and purple dots, respectively.
Fraction V Bovine Serum Albumin (Bsa, supplied by RPI Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/pmc10663058-121-28-34?v=RPI+Inc
Average 90 stars, based on 1 article reviews
fraction v bovine serum albumin (bsa - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Corning Life Sciences 96-well plates corning
RNAi is functional and the localizations of its contributors remain unchanged in HIV-expressing cells. (A) Silencing of EGFP expression by shGFP and miGFP remains functional in HIV-1 expressing cells. HeLa cells were co- transfected with 2 µg of pcDNA3 or pNL4-3, 1 µg of pEGFP-C1 and 4µg of shRNA-NS, shRNA-EGFP, miRNA-NS or miRNA-EGFP, as indicated. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (B) Inhibition of endogenous and transfected GAPDH expression by shGAPDH is functional in HIV- expressing cells. HeLa cells were co-transfected with 2 µg pcDNA3 or pNL4-3, 1 µg GAPDH-ProLabel and 1 µg pSIREN-shRNA-LucIRR or pSIREN-shRNA-GAPDHB. GAPDH, HIV-1 Gag and actin expression were observed by immunoblot and GAPDH silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (C) Inhibition of EGFP expression by let7 is functional in HIV-1 replicating cells. HeLa-CD4 (MAGI) cells were not infected (lanes 1, 2) or infected with pNL4-3 at one million RT cpms (lanes 3, 4) or 2 million RT cpms (lanes 5, 6) of supernatant. They were co-transfected with pEGFP or pEGFP-clet7 24 h later. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (D) The number of large GWBs is not altered in HIV-1 expressing cells. HeLa cells were transfected with 0.2 µg of HIV-1 pNL4-3. Cells were fixed and stained 48 h later with the human GWB marker serum 18033 and an antibody targeting HIV-1 p24. Side-by-side images of p24 positive (+ve) and negative (-ve) cells were identified and images were adjusted to visualize only large 18033 stained GWBs, which were then counted. The bar graph shows the mean number of GWBs from 12 pairs of cells. Statistical analysis was performed using an unpaired Mann-Whitney test (p=0.7) between +ve or –ve cells. (E-H) The localization of miRNA biogenesis enzymes and RNAi proteins in the cytoplasm is not altered in HIV-1 expressing cells . HeLa cells were transfected, fixed and stained as in (D) with the addition of antibodies against DDX6 (E), <t>Ago2</t> (F), TRBP (G) or Dicer (H). The size scale is 20 µm and is shown in each picture on the bottom left. Digitally zoomed images of the merged channels are shown on the far right, with arrows highlighting colocalization between the GWB marker 18033 and DDX6 (E) or Ago2 (F), shown as cyan and purple dots, respectively.
96 Well Plates Corning, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/polyclonal+anti-p24+rabbit+serum/pmc11584657-363-2-4?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
96-well plates corning - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Figure 2. mTOR activity is required for optimal viral-protein synthesis. (a) Schematic of experimental protocol. (b) HeLa cells were transfected with pNL4-3, left untreated or treated with 250 nM Torin1 in medium containing AHA. At the indicated times, cell lysates were collected and Click-it chemistry was performed followed by immunoprecipitation with rabbit anti-p24 antibody. Membranes were probed with the indicated antibodies. (c) Densitometry quantification of de novo synthesized, biotinylated Gag from panel b was determined by ImageJ analysis. For each time point, the values presented in the graph are normalized against the total amount of Gag in the cell lysate (refer to Supplementary Fig. 1 for total protein synthesis). Full-length blots are shown in Supplementary Fig. 5. (d) HeLa cells were transfected with either pcDNA3.1 or pNL4-3 and infected with L. major (lmj) WT or GP63 KO. Cell lysates were subjected to SDS-PAGE, immunoblotted and probed with the indicated antibodies against host (left panels) and viral (right panels) antigens.

Journal: Scientific reports

Article Title: HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases.

doi: 10.1038/s41598-017-05410-0

Figure Lengend Snippet: Figure 2. mTOR activity is required for optimal viral-protein synthesis. (a) Schematic of experimental protocol. (b) HeLa cells were transfected with pNL4-3, left untreated or treated with 250 nM Torin1 in medium containing AHA. At the indicated times, cell lysates were collected and Click-it chemistry was performed followed by immunoprecipitation with rabbit anti-p24 antibody. Membranes were probed with the indicated antibodies. (c) Densitometry quantification of de novo synthesized, biotinylated Gag from panel b was determined by ImageJ analysis. For each time point, the values presented in the graph are normalized against the total amount of Gag in the cell lysate (refer to Supplementary Fig. 1 for total protein synthesis). Full-length blots are shown in Supplementary Fig. 5. (d) HeLa cells were transfected with either pcDNA3.1 or pNL4-3 and infected with L. major (lmj) WT or GP63 KO. Cell lysates were subjected to SDS-PAGE, immunoblotted and probed with the indicated antibodies against host (left panels) and viral (right panels) antigens.

Article Snippet: The labeled material was precleared with normal rabbit serum and 25 μL of a 50:50 slurry of protein G-Sepharose (Thermo Scientific), incubated with rabbit anti-p24 (Fitzgerald) for 16 h at 4 °C and with 30 μL of a 50:50 slurry of protein G-Sepharose for 3 h at room temperature.

Techniques: Activity Assay, Transfection, Immunoprecipitation, Synthesized, Infection, SDS Page

Figure 5. RagA and RagB are necessary for HIV-1 to control LEL trafficking and for the viral budding and release. (a) HeLa cells, treated with non-silencing (NS) siRNA or siRNAs targeting RagA and RagB mRNAs, were transfected with empty vector control, pCDNA3.1 or HIV-1 using pNL4-3/GagmRFP, and then mock treated or treated with Ars. Cells were stained for mTOR (Cell Signaling 7C10) and LAMP-1. Light blue arrowheads identify HIV-1-expressing cells, while HIV-1-negative cells are indicated with green arrowheads. A dashed line contours individual cells. Scale bars are 10 μm. (b) The graphs represent the fluorescence intensities of mTOR (green) and LAMP-1 (blue) across the dashed lines from panel a. (c) The percentage of mock or HIV-1-transfected cells showing perinuclear clustering of LEL from panel a. The results are presented as the mean ± S.D. from three different experiments. P value is indicated by *(p < 0.05); n.s.: no signifcant difference between the means. (d) HeLa cells were co-transfected with the HIV-1 pNL4-3 and either non- sense (NS) siRNA or siRNA against RagA and RagB. HIV-1 particles were collected from the supernatant after filtration and ultracentrifugation. Cell lysates and virus particles were separated by SDS-PAGE, transferred to nitrocellulose and probed with the indicated antibodies. siRNA-mediated fold changes in RagA, RagB and virus production are indicated below insets in panel d in this representative experiment. Full-length blots are shown in Supplementary Fig. 5. (e) HeLa cells were co-transfected with the HIV-1 pNL4-3 and either non-sense (NS) siRNA or siRNA against RagA and RagB. Cells were fixed 24 h after transfection and stained for p24. (f) The percentage of HIV-1 and siRagA/B transfected cells showing peripheral accumulation of Gag from e. The results are presented as the mean ± S.D. from three different experiments. (g) HeLa cells were transfected as in e and subjected to transmission electron microscopy.

Journal: Scientific reports

Article Title: HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases.

doi: 10.1038/s41598-017-05410-0

Figure Lengend Snippet: Figure 5. RagA and RagB are necessary for HIV-1 to control LEL trafficking and for the viral budding and release. (a) HeLa cells, treated with non-silencing (NS) siRNA or siRNAs targeting RagA and RagB mRNAs, were transfected with empty vector control, pCDNA3.1 or HIV-1 using pNL4-3/GagmRFP, and then mock treated or treated with Ars. Cells were stained for mTOR (Cell Signaling 7C10) and LAMP-1. Light blue arrowheads identify HIV-1-expressing cells, while HIV-1-negative cells are indicated with green arrowheads. A dashed line contours individual cells. Scale bars are 10 μm. (b) The graphs represent the fluorescence intensities of mTOR (green) and LAMP-1 (blue) across the dashed lines from panel a. (c) The percentage of mock or HIV-1-transfected cells showing perinuclear clustering of LEL from panel a. The results are presented as the mean ± S.D. from three different experiments. P value is indicated by *(p < 0.05); n.s.: no signifcant difference between the means. (d) HeLa cells were co-transfected with the HIV-1 pNL4-3 and either non- sense (NS) siRNA or siRNA against RagA and RagB. HIV-1 particles were collected from the supernatant after filtration and ultracentrifugation. Cell lysates and virus particles were separated by SDS-PAGE, transferred to nitrocellulose and probed with the indicated antibodies. siRNA-mediated fold changes in RagA, RagB and virus production are indicated below insets in panel d in this representative experiment. Full-length blots are shown in Supplementary Fig. 5. (e) HeLa cells were co-transfected with the HIV-1 pNL4-3 and either non-sense (NS) siRNA or siRNA against RagA and RagB. Cells were fixed 24 h after transfection and stained for p24. (f) The percentage of HIV-1 and siRagA/B transfected cells showing peripheral accumulation of Gag from e. The results are presented as the mean ± S.D. from three different experiments. (g) HeLa cells were transfected as in e and subjected to transmission electron microscopy.

Article Snippet: The labeled material was precleared with normal rabbit serum and 25 μL of a 50:50 slurry of protein G-Sepharose (Thermo Scientific), incubated with rabbit anti-p24 (Fitzgerald) for 16 h at 4 °C and with 30 μL of a 50:50 slurry of protein G-Sepharose for 3 h at room temperature.

Techniques: Control, Transfection, Plasmid Preparation, Staining, Expressing, Fluorescence, Filtration, Virus, SDS Page, Transmission Assay, Electron Microscopy

Figure 6. RagA and RagB interact with Gag and Vif. (a) Lysates from control pcDNA3.1- or pNL4-3- transfected HeLa cells were subjected to immunoprecipitation with RagA antibodies. Samples were subjected to SDS-PAGE followed by transfer to nitrocellulose membranes and probed with the indicated antibodies. Full- length blots are shown in Supplementary Fig. 5. (b) Lysate from pcDNA3.1-, pNL4-3-, pNLXX−, pNLXX+ pSVGag− and pNLVif–transfected HeLa cells were subjected to immunoprecipitation with RagA and RagB antibodies or isotype rabbit IgG control. The blots were probed with anti-p24, anti-Vif, anti-RagA and anti- RagB antibodies. Full-length blots are shown in Supplementary Fig. 5. (c) HeLa cells were transfected with either pNLXX or pNLVif- and left untreated (Unt) or stressed with 500 µM Ars for 1 h. HIV-1-expressing cells were identified using FISH to localize vRNA and stained using antibodies against mTOR (Cell Signaling) and LAMP-1. Light blue arrowheads identify pNLXX or pNLVif- expressing cells, while pNLXX or pNLVif- negative cells in the same field are indicated with green arrowheads. A dashed line contours individual cells. Scale bars are 10 μm. (d) The percentage of mock, pNLXX or pNLVif- transfected cells showing perinuclear clustering of mTOR/LAMP-1 from panel c. The results are presented as the mean ± S.D. from three different experiments. P value is indicated by *(p < 0.05).

Journal: Scientific reports

Article Title: HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases.

doi: 10.1038/s41598-017-05410-0

Figure Lengend Snippet: Figure 6. RagA and RagB interact with Gag and Vif. (a) Lysates from control pcDNA3.1- or pNL4-3- transfected HeLa cells were subjected to immunoprecipitation with RagA antibodies. Samples were subjected to SDS-PAGE followed by transfer to nitrocellulose membranes and probed with the indicated antibodies. Full- length blots are shown in Supplementary Fig. 5. (b) Lysate from pcDNA3.1-, pNL4-3-, pNLXX−, pNLXX+ pSVGag− and pNLVif–transfected HeLa cells were subjected to immunoprecipitation with RagA and RagB antibodies or isotype rabbit IgG control. The blots were probed with anti-p24, anti-Vif, anti-RagA and anti- RagB antibodies. Full-length blots are shown in Supplementary Fig. 5. (c) HeLa cells were transfected with either pNLXX or pNLVif- and left untreated (Unt) or stressed with 500 µM Ars for 1 h. HIV-1-expressing cells were identified using FISH to localize vRNA and stained using antibodies against mTOR (Cell Signaling) and LAMP-1. Light blue arrowheads identify pNLXX or pNLVif- expressing cells, while pNLXX or pNLVif- negative cells in the same field are indicated with green arrowheads. A dashed line contours individual cells. Scale bars are 10 μm. (d) The percentage of mock, pNLXX or pNLVif- transfected cells showing perinuclear clustering of mTOR/LAMP-1 from panel c. The results are presented as the mean ± S.D. from three different experiments. P value is indicated by *(p < 0.05).

Article Snippet: The labeled material was precleared with normal rabbit serum and 25 μL of a 50:50 slurry of protein G-Sepharose (Thermo Scientific), incubated with rabbit anti-p24 (Fitzgerald) for 16 h at 4 °C and with 30 μL of a 50:50 slurry of protein G-Sepharose for 3 h at room temperature.

Techniques: Control, Transfection, Immunoprecipitation, SDS Page, Expressing, Staining

RNAi is functional and the localizations of its contributors remain unchanged in HIV-expressing cells. (A) Silencing of EGFP expression by shGFP and miGFP remains functional in HIV-1 expressing cells. HeLa cells were co- transfected with 2 µg of pcDNA3 or pNL4-3, 1 µg of pEGFP-C1 and 4µg of shRNA-NS, shRNA-EGFP, miRNA-NS or miRNA-EGFP, as indicated. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (B) Inhibition of endogenous and transfected GAPDH expression by shGAPDH is functional in HIV- expressing cells. HeLa cells were co-transfected with 2 µg pcDNA3 or pNL4-3, 1 µg GAPDH-ProLabel and 1 µg pSIREN-shRNA-LucIRR or pSIREN-shRNA-GAPDHB. GAPDH, HIV-1 Gag and actin expression were observed by immunoblot and GAPDH silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (C) Inhibition of EGFP expression by let7 is functional in HIV-1 replicating cells. HeLa-CD4 (MAGI) cells were not infected (lanes 1, 2) or infected with pNL4-3 at one million RT cpms (lanes 3, 4) or 2 million RT cpms (lanes 5, 6) of supernatant. They were co-transfected with pEGFP or pEGFP-clet7 24 h later. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (D) The number of large GWBs is not altered in HIV-1 expressing cells. HeLa cells were transfected with 0.2 µg of HIV-1 pNL4-3. Cells were fixed and stained 48 h later with the human GWB marker serum 18033 and an antibody targeting HIV-1 p24. Side-by-side images of p24 positive (+ve) and negative (-ve) cells were identified and images were adjusted to visualize only large 18033 stained GWBs, which were then counted. The bar graph shows the mean number of GWBs from 12 pairs of cells. Statistical analysis was performed using an unpaired Mann-Whitney test (p=0.7) between +ve or –ve cells. (E-H) The localization of miRNA biogenesis enzymes and RNAi proteins in the cytoplasm is not altered in HIV-1 expressing cells . HeLa cells were transfected, fixed and stained as in (D) with the addition of antibodies against DDX6 (E), Ago2 (F), TRBP (G) or Dicer (H). The size scale is 20 µm and is shown in each picture on the bottom left. Digitally zoomed images of the merged channels are shown on the far right, with arrows highlighting colocalization between the GWB marker 18033 and DDX6 (E) or Ago2 (F), shown as cyan and purple dots, respectively.

Journal: bioRxiv

Article Title: The sequestration of miR-642a-3p by a complex formed by HIV-1 Gag and human Dicer increases AFF4 expression and viral production

doi: 10.1101/2023.05.24.542197

Figure Lengend Snippet: RNAi is functional and the localizations of its contributors remain unchanged in HIV-expressing cells. (A) Silencing of EGFP expression by shGFP and miGFP remains functional in HIV-1 expressing cells. HeLa cells were co- transfected with 2 µg of pcDNA3 or pNL4-3, 1 µg of pEGFP-C1 and 4µg of shRNA-NS, shRNA-EGFP, miRNA-NS or miRNA-EGFP, as indicated. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (B) Inhibition of endogenous and transfected GAPDH expression by shGAPDH is functional in HIV- expressing cells. HeLa cells were co-transfected with 2 µg pcDNA3 or pNL4-3, 1 µg GAPDH-ProLabel and 1 µg pSIREN-shRNA-LucIRR or pSIREN-shRNA-GAPDHB. GAPDH, HIV-1 Gag and actin expression were observed by immunoblot and GAPDH silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (C) Inhibition of EGFP expression by let7 is functional in HIV-1 replicating cells. HeLa-CD4 (MAGI) cells were not infected (lanes 1, 2) or infected with pNL4-3 at one million RT cpms (lanes 3, 4) or 2 million RT cpms (lanes 5, 6) of supernatant. They were co-transfected with pEGFP or pEGFP-clet7 24 h later. EGFP, HIV-1 Gag and actin expression were observed by immunoblot and EGFP silencing effects in relation to paired nonsense controls were quantified by densitometry analysis. (D) The number of large GWBs is not altered in HIV-1 expressing cells. HeLa cells were transfected with 0.2 µg of HIV-1 pNL4-3. Cells were fixed and stained 48 h later with the human GWB marker serum 18033 and an antibody targeting HIV-1 p24. Side-by-side images of p24 positive (+ve) and negative (-ve) cells were identified and images were adjusted to visualize only large 18033 stained GWBs, which were then counted. The bar graph shows the mean number of GWBs from 12 pairs of cells. Statistical analysis was performed using an unpaired Mann-Whitney test (p=0.7) between +ve or –ve cells. (E-H) The localization of miRNA biogenesis enzymes and RNAi proteins in the cytoplasm is not altered in HIV-1 expressing cells . HeLa cells were transfected, fixed and stained as in (D) with the addition of antibodies against DDX6 (E), Ago2 (F), TRBP (G) or Dicer (H). The size scale is 20 µm and is shown in each picture on the bottom left. Digitally zoomed images of the merged channels are shown on the far right, with arrows highlighting colocalization between the GWB marker 18033 and DDX6 (E) or Ago2 (F), shown as cyan and purple dots, respectively.

Article Snippet: Cells were incubated with the primary antibodies for 1 h at 37 ℃ using mouse monoclonal anti-p24 (183-H12-5C) ( ) at a dilution of 1/400 or 1/1000, rabbit anti-p24 (from Dr. L. Kleiman) at a 1/1000 dilution, rabbit anti- Rck/p54/DDX6 (Bethyl labs) at a 1/1000 dilution, mouse anti-Ago2 (Wako 4G8) at a 1/100 dilution, rabbit anti-TRBP673 ( ) at a 1/250 dilution, rabbit anti-Dicer 349 ( ) at a 1/250 dilution, mouse monoclonal anti-Dicer 13D6 antibody (Abcam) at a 1/500 dilution and human autoimmune serum 18033 ( ) at a 1/5000 dilution.

Techniques: Functional Assay, Expressing, Transfection, shRNA, Western Blot, Inhibition, Infection, Staining, Marker, MANN-WHITNEY

GWB counts in side-by-side images of p24 +ve and –ve cells. HeLa cells were transfected with 0.2 μg of HIV-1 pNL4-3. 48 h later cells were fixed and stained with the human GWB marker serum 18033 (red), an antibody targeting HIV-1 p24 (blue) and an antibody targeting TRBP, Ago2 or Dicer (green). The level of red was adjusted with Adobe Photoshop so that only large GWBs (2-14 per cell) were visible. GWBs were then counted in side-by-side images of p24 –ve/+ve cells and recorded below the images.

Journal: bioRxiv

Article Title: The sequestration of miR-642a-3p by a complex formed by HIV-1 Gag and human Dicer increases AFF4 expression and viral production

doi: 10.1101/2023.05.24.542197

Figure Lengend Snippet: GWB counts in side-by-side images of p24 +ve and –ve cells. HeLa cells were transfected with 0.2 μg of HIV-1 pNL4-3. 48 h later cells were fixed and stained with the human GWB marker serum 18033 (red), an antibody targeting HIV-1 p24 (blue) and an antibody targeting TRBP, Ago2 or Dicer (green). The level of red was adjusted with Adobe Photoshop so that only large GWBs (2-14 per cell) were visible. GWBs were then counted in side-by-side images of p24 –ve/+ve cells and recorded below the images.

Article Snippet: Cells were incubated with the primary antibodies for 1 h at 37 ℃ using mouse monoclonal anti-p24 (183-H12-5C) ( ) at a dilution of 1/400 or 1/1000, rabbit anti-p24 (from Dr. L. Kleiman) at a 1/1000 dilution, rabbit anti- Rck/p54/DDX6 (Bethyl labs) at a 1/1000 dilution, mouse anti-Ago2 (Wako 4G8) at a 1/100 dilution, rabbit anti-TRBP673 ( ) at a 1/250 dilution, rabbit anti-Dicer 349 ( ) at a 1/250 dilution, mouse monoclonal anti-Dicer 13D6 antibody (Abcam) at a 1/500 dilution and human autoimmune serum 18033 ( ) at a 1/5000 dilution.

Techniques: Transfection, Staining, Marker

(Top) In the absence of HIV-1, miR-642a-3p is loaded on Dicer-TRBP, which recruits Ago2 to form the RNA-induced silencing complex (RISC). miR-642a-3p targets and silences AFF4 mRNA, resulting in a poor assembly of the super elongation complex (SEC) and paused RNA polymerase (Pol) II. (Bottom) In the presence of HIV-1, Gag binds to Dicer, which induces the sequestration of miR-642a- 3p and prevents its loading on the RISC. AFF4 mRNA is translated, which results in the formation of an active SEC including AFF4 and a processive RNA Pol II.

Journal: bioRxiv

Article Title: The sequestration of miR-642a-3p by a complex formed by HIV-1 Gag and human Dicer increases AFF4 expression and viral production

doi: 10.1101/2023.05.24.542197

Figure Lengend Snippet: (Top) In the absence of HIV-1, miR-642a-3p is loaded on Dicer-TRBP, which recruits Ago2 to form the RNA-induced silencing complex (RISC). miR-642a-3p targets and silences AFF4 mRNA, resulting in a poor assembly of the super elongation complex (SEC) and paused RNA polymerase (Pol) II. (Bottom) In the presence of HIV-1, Gag binds to Dicer, which induces the sequestration of miR-642a- 3p and prevents its loading on the RISC. AFF4 mRNA is translated, which results in the formation of an active SEC including AFF4 and a processive RNA Pol II.

Article Snippet: Cells were incubated with the primary antibodies for 1 h at 37 ℃ using mouse monoclonal anti-p24 (183-H12-5C) ( ) at a dilution of 1/400 or 1/1000, rabbit anti-p24 (from Dr. L. Kleiman) at a 1/1000 dilution, rabbit anti- Rck/p54/DDX6 (Bethyl labs) at a 1/1000 dilution, mouse anti-Ago2 (Wako 4G8) at a 1/100 dilution, rabbit anti-TRBP673 ( ) at a 1/250 dilution, rabbit anti-Dicer 349 ( ) at a 1/250 dilution, mouse monoclonal anti-Dicer 13D6 antibody (Abcam) at a 1/500 dilution and human autoimmune serum 18033 ( ) at a 1/5000 dilution.

Techniques: